BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15355102)

  • 1. A transition state analogue for an RNA-editing reaction.
    Haudenschild BL; Maydanovych O; Véliz EA; Macbeth MR; Bass BL; Beal PA
    J Am Chem Soc; 2004 Sep; 126(36):11213-9. PubMed ID: 15355102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting sites of ADAR editing in double-stranded RNA.
    Eggington JM; Greene T; Bass BL
    Nat Commun; 2011; 2():319. PubMed ID: 21587236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding selectivity of ADAR2's dsRBMs contributes to RNA-editing selectivity.
    Stephens OM; Haudenschild BL; Beal PA
    Chem Biol; 2004 Sep; 11(9):1239-50. PubMed ID: 15380184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA sequences that direct selective ADAR editing from a SELEX library bearing 8-azanebularine.
    Wong BL; Mendoza HG; Jacobsen CS; Beal PA
    Bioorg Med Chem; 2024 Apr; 104():117700. PubMed ID: 38583236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
    Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
    Pfaller CK; George CX; Samuel CE
    Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2.
    Yi-Brunozzi HY; Easterwood LM; Kamilar GM; Beal PA
    Nucleic Acids Res; 1999 Jul; 27(14):2912-7. PubMed ID: 10390533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing adenosine-to-inosine editing reactions using RNA-containing nucleoside analogs.
    Maydanovych O; Easterwood LM; Cui T; Véliz EA; Pokharel S; Beal PA
    Methods Enzymol; 2007; 424():369-86. PubMed ID: 17662850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matching active site and substrate structures for an RNA editing reaction.
    Pokharel S; Jayalath P; Maydanovych O; Goodman RA; Wang SC; Tantillo DJ; Beal PA
    J Am Chem Soc; 2009 Aug; 131(33):11882-91. PubMed ID: 19642681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of duplex RNA by the deaminase domain of the RNA editing enzyme ADAR2.
    Phelps KJ; Tran K; Eifler T; Erickson AI; Fisher AJ; Beal PA
    Nucleic Acids Res; 2015 Jan; 43(2):1123-32. PubMed ID: 25564529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.
    Thuy-Boun AS; Thomas JM; Grajo HL; Palumbo CM; Park S; Nguyen LT; Fisher AJ; Beal PA
    Nucleic Acids Res; 2020 Aug; 48(14):7958-7972. PubMed ID: 32597966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme.
    Mizrahi RA; Shin D; Sinkeldam RW; Phelps KJ; Fin A; Tantillo DJ; Tor Y; Beal PA
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8713-6. PubMed ID: 26095193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
    Jaikaran DC; Collins CH; MacMillan AM
    J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design.
    Véliz EA; Easterwood LM; Beal PA
    J Am Chem Soc; 2003 Sep; 125(36):10867-76. PubMed ID: 12952466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deamination of mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deaminase: similarities to in vivo RNA editing.
    Hurst SR; Hough RF; Aruscavage PJ; Bass BL
    RNA; 1995 Dec; 1(10):1051-60. PubMed ID: 8595560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.
    Samuel CE
    Virology; 2011 Mar; 411(2):180-93. PubMed ID: 21211811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analogs in the study of the epitranscriptome.
    Palumbo CM; Beal PA
    Methods; 2019 Mar; 156():46-52. PubMed ID: 30827466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
    Mannion N; Arieti F; Gallo A; Keegan LP; O'Connell MA
    Biomolecules; 2015 Sep; 5(4):2338-62. PubMed ID: 26437436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.